ProfileGDS4718 / 205648_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 43% 39% 42% 41% 46% 67% 43% 40% 41% 39% 45% 56% 58% 57% 44% 36% 61% 53% 78% 39% 39% 39% 43% 43% 58% 39% 51% 39% 52% 40% 58% 46% 36% 62% 65% 51% 45% 40% 40% 35% 54% 79% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.236345
GSM549102patient 115, normal, homogenized [OPG study]5.1761443
GSM549104patient 119, normal, homogenized [OPG study]4.9436239
GSM549108patient 138, normal, homogenized [OPG study]5.1433342
GSM549119patient 077, normal, homogenized [OPG study]5.0304141
GSM549133patient 032, cancer, homogenized [OPG study]5.2638346
GSM549139patient 042, cancer, homogenized [OPG study]6.6110767
GSM549099patient 107, normal, homogenized [OPG study]5.1640143
GSM549109patient 139, normal, homogenized [OPG study]5.0239140
GSM549110patient 046, normal, homogenized [OPG study]5.0541241
GSM549114patient 063, normal, homogenized [OPG study]4.8895439
GSM549122patient 082, normal, homogenized [OPG study]5.2529745
GSM549134patient 033, cancer, homogenized [OPG study]5.8176756
GSM549136patient 036, cancer, homogenized [OPG study]5.9412158
GSM549140patient 044, cancer, homogenized [OPG study]5.9361557
GSM549111patient 047, normal, homogenized [OPG study]5.1735744
GSM549113patient 057, normal, homogenized [OPG study]4.7601636
GSM549132patient 031, cancer, homogenized [OPG study]6.1661861
GSM549137patient 038, cancer, homogenized [OPG study]5.6803253
GSM549142patient 047, cancer, homogenized [OPG study]7.4073878
GSM549100patient 110, normal, homogenized [OPG study]4.9755139
GSM549107patient 135, normal, homogenized [OPG study]4.8878739
GSM549115patient 068, normal, homogenized [OPG study]4.8620139
GSM549116patient 072, normal, homogenized [OPG study]5.0898143
GSM549120patient 078, normal, homogenized [OPG study]5.1350243
GSM549131patient 030, cancer, homogenized [OPG study]5.9706458
GSM549118patient 074, normal, homogenized [OPG study]4.9256339
GSM549129patient 027, cancer, homogenized [OPG study]5.5836351
GSM549123patient 088, normal, homogenized [OPG study]4.9372439
GSM549124patient 006, cancer, homogenized [OPG study]5.6470352
GSM549126patient 015, cancer, homogenized [OPG study]5.0094740
GSM549128patient 025, cancer, homogenized [OPG study]6.032458
GSM549103patient 117, normal, homogenized [OPG study]5.3546
GSM549117patient 073, normal, homogenized [OPG study]4.7889336
GSM549138patient 041, cancer, homogenized [OPG study]6.3047362
GSM549141patient 045, cancer, homogenized [OPG study]6.4952865
GSM549130patient 028, cancer, homogenized [OPG study]5.5842551
GSM549101patient 111, normal, homogenized [OPG study]5.2892745
GSM549105patient 128, normal, homogenized [OPG study]4.998240
GSM549106patient 134, normal, homogenized [OPG study]4.9222340
GSM549112patient 048, normal, homogenized [OPG study]4.7362835
GSM549125patient 011, cancer, homogenized [OPG study]5.7346154
GSM549127patient 024, cancer, homogenized [OPG study]7.76879
GSM549135patient 035, cancer, homogenized [OPG study]5.7377654